Replies to post #449 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

Re: Insider buying

The CEO, CMO, and the acting CFO have 10b5-1 selling plans in effect, so they aren’t going to be buying shares in the near future. That leaves the COO and the independent directors as possible open-market buyers.

In fact, two independent directors have bought open-market shares during the past nine months:

https://www.sec.gov/Archives/edgar/data/1479290/000147929018000052/xslF345X03/wf-form4_152124512506409.xml (Mar 2018: 3,150 sh@$31.20; ~$100K worth)

https://www.sec.gov/Archives/edgar/data/1479290/000120919117060104/xslF345X03/doc4.xml (Nov 2017: 20K sh@~$27; ~$540K worth)